Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
Identifieur interne : 001F70 ( Ncbi/Curation ); précédent : 001F69; suivant : 001F71Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
Auteurs : Minori Enomoto [Japon] ; Yuichi Inoue ; Kazuyoshi Namba ; Takashi Munezawa ; Masato MatsuuraSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2008.
English descriptors
- KwdEn :
- Adult, Age of Onset, Aged, Anticonvulsants (therapeutic use), Azepines (therapeutic use), Clonazepam (therapeutic use), Dopamine Agents (therapeutic use), Female, Humans, Kidney Failure, Chronic (complications), Kidney Failure, Chronic (therapy), Male, Middle Aged, Peritoneal Dialysis, Polysomnography, Renal Dialysis, Restless Legs Syndrome (drug therapy), Restless Legs Syndrome (etiology), Restless Legs Syndrome (physiopathology), Treatment Outcome, Uremia (complications), Uremia (therapy).
- MESH :
- chemical , therapeutic use : Anticonvulsants, Azepines, Clonazepam, Dopamine Agents.
- complications : Kidney Failure, Chronic, Uremia.
- drug therapy : Restless Legs Syndrome.
- etiology : Restless Legs Syndrome.
- physiopathology : Restless Legs Syndrome.
- therapy : Kidney Failure, Chronic, Uremia.
- Adult, Age of Onset, Aged, Female, Humans, Male, Middle Aged, Peritoneal Dialysis, Polysomnography, Renal Dialysis, Treatment Outcome.
Abstract
This study was done to identify the clinical characteristics of uremic restless legs syndrome (RLS). Consecutive uremic RLS patients (n = 15) and idiopathic RLS patients (iRLS; n = 20) were evaluated. The groups were compared with respect to their clinical course, subjective symptoms [using the Pittsburgh Sleep Quality Index (PSQI) and the International Restless Legs Syndrome Severity Scale (IRLS)], polysomnographic (PSG) variables, the results of the suggested immobilization test (SIT), and the drug doses used to treat RLS. The duration of the disorder was significantly shorter in the uremic RLS group than in the iRLS group. The PSQI and IRLS scores before treatment were higher in the uremic RLS group than in the iRLS group. The periodic leg movement index (PLM index) on PSG and the SIT index were also higher in the uremic RLS group (P < 0.001, respectively). The bromocriptine equivalent dose of dopaminergic agonists used to treat RLS was significantly higher in the uremic RLS group (P < 0.001). Uremic RLS appears to deteriorate faster and to become more severe than iRLS. Moreover, uremic RLS patients appear to have a decreased response to dopaminergic agonists.
DOI: 10.1002/mds.21882
PubMed: 18074382
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002389
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002389
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002380
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001F70
Links to Exploration step
pubmed:18074382Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.</title><author><name sortKey="Enomoto, Minori" sort="Enomoto, Minori" uniqKey="Enomoto M" first="Minori" last="Enomoto">Minori Enomoto</name><affiliation wicri:level="3"><nlm:affiliation>Japan Somnology center, Neuropsychiatric Research Institute, Tokyo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Japan Somnology center, Neuropsychiatric Research Institute, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Inoue, Yuichi" sort="Inoue, Yuichi" uniqKey="Inoue Y" first="Yuichi" last="Inoue">Yuichi Inoue</name></author><author><name sortKey="Namba, Kazuyoshi" sort="Namba, Kazuyoshi" uniqKey="Namba K" first="Kazuyoshi" last="Namba">Kazuyoshi Namba</name></author><author><name sortKey="Munezawa, Takashi" sort="Munezawa, Takashi" uniqKey="Munezawa T" first="Takashi" last="Munezawa">Takashi Munezawa</name></author><author><name sortKey="Matsuura, Masato" sort="Matsuura, Masato" uniqKey="Matsuura M" first="Masato" last="Matsuura">Masato Matsuura</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="doi">10.1002/mds.21882</idno><idno type="RBID">pubmed:18074382</idno><idno type="pmid">18074382</idno><idno type="wicri:Area/PubMed/Corpus">002389</idno><idno type="wicri:Area/PubMed/Curation">002389</idno><idno type="wicri:Area/PubMed/Checkpoint">002380</idno><idno type="wicri:Area/Ncbi/Merge">001F70</idno><idno type="wicri:Area/Ncbi/Curation">001F70</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.</title><author><name sortKey="Enomoto, Minori" sort="Enomoto, Minori" uniqKey="Enomoto M" first="Minori" last="Enomoto">Minori Enomoto</name><affiliation wicri:level="3"><nlm:affiliation>Japan Somnology center, Neuropsychiatric Research Institute, Tokyo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Japan Somnology center, Neuropsychiatric Research Institute, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Inoue, Yuichi" sort="Inoue, Yuichi" uniqKey="Inoue Y" first="Yuichi" last="Inoue">Yuichi Inoue</name></author><author><name sortKey="Namba, Kazuyoshi" sort="Namba, Kazuyoshi" uniqKey="Namba K" first="Kazuyoshi" last="Namba">Kazuyoshi Namba</name></author><author><name sortKey="Munezawa, Takashi" sort="Munezawa, Takashi" uniqKey="Munezawa T" first="Takashi" last="Munezawa">Takashi Munezawa</name></author><author><name sortKey="Matsuura, Masato" sort="Matsuura, Masato" uniqKey="Matsuura M" first="Masato" last="Matsuura">Masato Matsuura</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Age of Onset</term><term>Aged</term><term>Anticonvulsants (therapeutic use)</term><term>Azepines (therapeutic use)</term><term>Clonazepam (therapeutic use)</term><term>Dopamine Agents (therapeutic use)</term><term>Female</term><term>Humans</term><term>Kidney Failure, Chronic (complications)</term><term>Kidney Failure, Chronic (therapy)</term><term>Male</term><term>Middle Aged</term><term>Peritoneal Dialysis</term><term>Polysomnography</term><term>Renal Dialysis</term><term>Restless Legs Syndrome (drug therapy)</term><term>Restless Legs Syndrome (etiology)</term><term>Restless Legs Syndrome (physiopathology)</term><term>Treatment Outcome</term><term>Uremia (complications)</term><term>Uremia (therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticonvulsants</term><term>Azepines</term><term>Clonazepam</term><term>Dopamine Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Kidney Failure, Chronic</term><term>Uremia</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Restless Legs Syndrome</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Restless Legs Syndrome</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Restless Legs Syndrome</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Kidney Failure, Chronic</term><term>Uremia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Age of Onset</term><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Peritoneal Dialysis</term><term>Polysomnography</term><term>Renal Dialysis</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study was done to identify the clinical characteristics of uremic restless legs syndrome (RLS). Consecutive uremic RLS patients (n = 15) and idiopathic RLS patients (iRLS; n = 20) were evaluated. The groups were compared with respect to their clinical course, subjective symptoms [using the Pittsburgh Sleep Quality Index (PSQI) and the International Restless Legs Syndrome Severity Scale (IRLS)], polysomnographic (PSG) variables, the results of the suggested immobilization test (SIT), and the drug doses used to treat RLS. The duration of the disorder was significantly shorter in the uremic RLS group than in the iRLS group. The PSQI and IRLS scores before treatment were higher in the uremic RLS group than in the iRLS group. The periodic leg movement index (PLM index) on PSG and the SIT index were also higher in the uremic RLS group (P < 0.001, respectively). The bromocriptine equivalent dose of dopaminergic agonists used to treat RLS was significantly higher in the uremic RLS group (P < 0.001). Uremic RLS appears to deteriorate faster and to become more severe than iRLS. Moreover, uremic RLS patients appear to have a decreased response to dopaminergic agonists.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F70 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001F70 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:18074382
|texte= Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:18074382" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |